Evaluation of the SERM Ormeloxifene in the Treatment of Uterine Fibroid in the Reproductive Age Group
Journal of Syndromes
doi 10.13188/2380-6036.1000011
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Unknown
Publisher
Avens Publishing Group